UK OTC Group Chief Outlines Cautious Brexit Stance
This article was originally published in The Pink Sheet & The Rose Sheet
Executive Summary
Proprietary Association of Great Britain urges UK and EU to “ensure appropriate mutual recognition agreements are in place” following UK's Brexit withdrawal, says chief executive John Smith.
You may also be interested in...
Brexit Bites EMA: Huge Staff Losses Freeze Many Projects
The EMA is halting its cherished transparency initiative on study data as it reckons with the fact that many of its employees will not be relocating to its new headquarters in Amsterdam. International collaboration, guidelines development and revision, and the agency's involvement in stakeholder meetings will all be cut back.
Long-Awaited Brexit White Paper Lays Out UK’s Plans For Medicines Regulation
The UK government has finally published its white paper on the UK’s future relationship with the EU following Brexit, to the relief of the pharmaceutical industry.
Sweden Seeks To Tackle Opioid Overdose Deaths With Naloxone Rx-To-OTC Switch
Opioid antagonist naloxone will soon be available without prescription in Sweden following a successful Rx-to-OTC application from Norway's DNE Pharma.